← Back to Clinical Trials
Recruiting NCT06797050

NCT06797050 A Story for Pepper & Nao

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06797050
Status Recruiting
Phase
Sponsor IRCCS Fondazione Stella Maris
Condition Children and Adolescents With Neuromotor Impairment
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-04-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 16 Years
Study Type INTERVENTIONAL
Interventions
Training in reordering figurative stories with a social robot through the Learning by Teaching approach

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-04-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the present study is to improve cognitive processes that are frequently impaired in children characterised by neuromotor impairment, such as the skills of visual-perceptual analysis and selective attention, working memory, narrative organisation, logical-inferential reasoning and motor planning. For this purpose, a task of reordering figurative stories and action sequences, which include the aforementioned processes, will be used through an innovative Learning by Teaching training paradigm with a social robot. Furthermore, the study aims to verify the children's level of behavioural, cognitive and emotional engagement during the interaction with the social robot and to test the generalisation effects of the intervention on other processes, such as working memory, inhibition and planning.

Eligibility Criteria

Inclusion Criteria: * Children characterized by neuromotor impairment * Presence of at least one cognitive index \>70 at WISC-IV or WISC V * Age between 7 and 16 years at the time of recruitment Exclusion Criteria: * Severe neurological, motor, or sensory deficit such as to preclude the feasibility of training * Psychiatric comorbidity such as to preclude the feasibility of training

Contact & Investigator

Central Contact

Giuseppina Sgandurra, PhD, MD

✉ giuseppina.sgandurra@fsm.unipi.it

📞 050/886233

Frequently Asked Questions

Who can join the NCT06797050 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 16 Years, studying Children and Adolescents With Neuromotor Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06797050 currently recruiting?

Yes, NCT06797050 is actively recruiting participants. Contact the research team at giuseppina.sgandurra@fsm.unipi.it for enrollment information.

Where is the NCT06797050 trial being conducted?

This trial is being conducted at Bosisio Parini, Italy, Pavia, Italy, Calambrone, Italy.

Who is sponsoring the NCT06797050 clinical trial?

NCT06797050 is sponsored by IRCCS Fondazione Stella Maris. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology